Lisdexamfetamine Dimesylate

Global calcium is one of the leading manufacturers and exporters of Lisdexamfetamine dimesilate CAS No. 608137-33-3, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, global calcium has stood the test of time since its inception in 1979.

As manufacturer of Lisdexamfetamine dimesylate we hereby state the following facts about the drug:

Lisdexamfetamine dimesylate is a prescription central nervous system (CNS) stimulant used to treat attention-deficit/hyperactivity disorder (ADHD) and moderate to severe binge eating disorder (BED)

 Indication:

Lisdexamfetamine dimesylate is used to treat attention deficit hyperactivity disorder (ADHD) in adults and children 6 years of age and older.

Mechanism of action;

Lisdexamfetamine is a prodrug that is converted in the blood to its active form, d-amphetamine, which then increases the levels of dopamine and norepinephrine in the brain.